Eddie is a co-founder of Akili, a digital medicine company creating treatments and assessments for cognitive disorders that are delivered through immersive, high quality video game mechanics. As part of PureTech Health, Eddie previously co-founded two other health-focused start-ups, and helped launch their digital health initiative. He was previously a Kauffman Entrepreneur Fellow, a program sponsored by the Kauffman Foundation of Kansas City, MO, focused on healthcare entrepreneurship. Prior to that, he completed his graduate work at Yale University in the Departments of Pharmacology and Molecular Biophysics & Biochemistry, focusing on structure-based drug design. Eddie received his B.S. in Biochemistry from Providence College, and his M.Phil. and Ph.D. from Yale University.
Eddie frequently serves on discussion panels for industry and academic events related to healthcare innovation, has appeared in media including CNN’s Vital Signs with Sanjay Gupta, and Akili has received recognition including the 2014 Future of Health Technology product award, 2015 50-on-Fire Boston, and the #1 health company in Entrepreneur magazine’s 100 Brilliant Companies of 2016.
Digital Therapeutics (DTx), defined as software-driven evidence-based therapeutic medical interventions, are used increasingly for conditions not well-addressed by mainstream medicine. These therapies collect information on a new frontier: a patient’s moment-by-moment physiological processes, emotions, behaviors, and environment. How should these highly personalized tools be implemented? How should this flood of data be governed and analyzed? How will the increased information affect the provider’s role? A panel of DTx developers will address these questions and more.